Nutlin-3a suppresses poly (ADP-ribose) polymerase 1 by mechanisms different from conventional PARP1 suppressors in a human breast cancer cell line

Overview of attention for article published in Oncotarget, May 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 16 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them

Grant US-11603367-B2

United States of America

BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS

Application WO-2022185260-A1

World Intellectual Property Organisation (WIPO)